期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF CLINICAL APHERESIS LetPub Score 6.0
50 ratings
Rate
Reputation 7.3 Influence 4.7 Speed 7.0 | ||||||||||||||||
期刊簡稱 | J CLIN APHERESIS | ||||||||||||||||
ISSN | 0733-2459 | ||||||||||||||||
E-ISSN | 1098-1101 | ||||||||||||||||
h-index | 43 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 7.10%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-1101 | ||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/jca | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Wiley-Liss Inc. | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 1982 | ||||||||||||||||
每年文章數 | 54每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 19.47% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0733-2459%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[JOURNAL OF CLINICAL APHERESIS] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:39:55 評論於 Authors should first conduct a search and analysis in SCI and Scopus databases. Secondly, they should carefully read the submission guidelines of the target journal, and review the recent issues and related articles to confirm whether their manuscript aligns with the journal's scope(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:32:23 評論於 3-5 suggested journals(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 13:41:51 評論於 Which ones are more suitable to choose for publication in the future?(0) 讚! | 深渊兴业 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 09:13:00 評論於 How to evaluate the impact factor of your own articles, or how to better position your articles?(0) 讚! | 北国博达 |
作者: Tiffany Stevenson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-11-17 13:07:59 評論於 Can you tell me who are the reviewers of this magazine? It took a total of four months, which is quite slow, but in the end, it turned out pretty well(0) 讚! | Tiffany Stevenson |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 12:31:01 評論於 Too harsh! After falling so much, who dares to invest in the future??(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 10:16:09 評論於 It's frustrating. I received over 2 points for my publication last year, but this year it's just over 1 point. Will it decrease even more next year? Who would be willing to publish it?(0) 讚! | 凌霄高洁 |
作者: 震雷成业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-01-12 08:54:25 評論於 It took a total of 4 months, kind of slow, but in the end, it paid off(0) 讚! | 震雷成业 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-07-01 17:47:06 評論於 We are two points away now, and next year we might have a chance to get closer. There is a lot of hope(0) 讚! | 凌霄高洁 |
作者: 風見冬菱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-10-14 09:48:07 評論於 I am very happy to see this journal increase its impact factor. I submitted last year, and the review process was very nice, with one month for the first review and one month for the second review. They raised some questions, but also gave some helpful suggestions for answering them. It took a total of 4 months from submission to online publication. I didn't originally have high expectations, as I had never submitted to this journal before and it has fewer articles, but in the end, it was accepted. I am happy(0) 讚! | 風見冬菱 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us